JLK, Inc. (322510.KQ) has a MoatMap StockRank of 3/100 based on Quality (15/100), Value (38/100), and Momentum (23/100) factor scores. The current signal is STRONG SELL.
JLK, Inc. provides diagnosis support to the patients with its AI-driven medical platform in South Korea. The company offers AI medical and AI security solutions.
| Price | $2.80 |
| Market Cap | $73M |
| Price/Book | 2.59 |
| Return on Equity | -33.5% |
| Return on Invested Capital | -24.1% |
| Debt/Equity | 80.17 |
| Gross Margin | 98.0% |
| Operating Margin | -819.8% |
| Revenue Growth | -15.1% |
| Free Cash Flow | $-5K |
JLK, Inc. operates in the Conglomerates industry, part of the Industrials sector (South Korea).